Cite

HARVARD Citation

    Ivanov, V. et al. (n.d.). Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma. Leukemia & lymphoma. 55 (11), pp. 2508-2513. [Online]. 
  
Back to record